Merriman Capital Announces Sponsorship of Medifocus on OTCQX

SAN FRANCISCO, June 30, 2011 /PRNewswire/ -- Merriman Capital, Inc., a wholly owned subsidiary of Merriman Holdings, Inc. (NASDAQ: MERR), today announced that it will serve as the Principal American Liaison (PAL) for Medifocus, Inc. (OTCQX: MDFZF; TSX.V: MFS) as it begins trading on OTCQX®.  

(Logo:  http://photos.prnewswire.com/prnh/20100914/SF64919LOGO)

Medifocus owns a patented adaptive phased array (APA) microwave focusing technology platform that can precisely target and concentrate microwave energy to destroy cancer tumors without damaging healthy tissue when used alone or in conjunction with chemotherapy or radiation.  The Company announced today that it is now trading on the OTC market's highest tier, OTCQX.

OTCQX distinguishes the best companies traded over-the-counter (OTC) from more than 9,000 securities traded on the OTCBB and OTC Link that are not required to meet any financial standards or undergo a qualitative review.

Spencer Grimes, Merriman Capital Managing Director, said: "Medifocus has its main operations in the United States and will be starting a pivotal breast cancer treatment study in this country, so it is natural for the Company to increase its exposure to U.S. investors.  We are proud to partner with Medifocus in this effort, and joining OTCQX is a great first step."

Dr. Augustine Y. Cheung, CEO of Medifocus, commented: "Having our shares trade on OTCQX, in addition to our Canadian presence on the TSX.V, provides Medifocus with an excellent method of accessing the U.S. capital markets, while providing U.S. investors with the accessibility, transparency and liquidity necessary for potential shareholders to feel comfortable when making an investment decision.  The U.S. breast cancer marketplace is 10 times the size of Canada's; thus we believe we will be able to attract an increased number of investors and greater interest from the U.S. capital markets."

About Merriman Capital, Inc.

Merriman Capital, Inc. is a full-service investment banking firm that provides investment banking, sales and trading, and equity research services to corporate and institutional clients and high net worth investors. Merriman Capital, Inc. is a wholly owned subsidiary of Merriman Holdings, Inc., which is listed on the NASDAQ Stock Market and trades under the symbol "MERR."

Merriman specializes in four growth sector industries: Technology, Telecom, Consumer, Media & Internet and CleanTech Infrastructure. For more information, please go to http://www.merrimanco.com/.

Merriman Capital, Inc. is a registered broker-dealer and member of The Financial Industry Regulatory Authority (FINRA) http://www.finra.org and the Securities Investor Protection Corporation (SIPC) http://www.sipc.org/contact.cfm.

About Medifocus, Inc.

Medifocus, Inc. (OTCQX: MDFZF; TSX.V: MFS) trades in the United States on OTCQX under the symbol "MDFZF."  Medifocus owns a patented adaptive phased array (APA) microwave focusing technology platform which can precisely target and concentrate microwave energy to destroy cancer tumors without damaging healthy tissue when used alone or in conjunction with chemotherapy or radiation.  The ability to target tumors with a precision controlled dose of heat can be used to destroy tumors at higher temperatures, to treat tumors in combination with chemotherapy and/or radiation at moderate temperatures for increased effectiveness over those treatments alone, and to activate temperature sensitive drugs for tumor targeted localized drug delivery.  Medifocus has completed the development of a dedicated commercial cancer treatment system for the treatment of breast cancer and is actively pursuing development of additional systems for other cancers.  Website: www.medifocusinc.com.

About OTCQX

The OTCQX marketplace is the premier tier of the U.S. OTC market.  Investor-focused companies use the quality-controlled OTCQX platform to offer investors transparent trading, superior information, and easy access through their regulated U.S. broker-dealers.  The innovative OTCQX platform offers companies and their shareholders a level of marketplace services formerly available only on a U.S. stock exchange.  For more information and to view a full list of OTCQX companies, visit www.otcqx.com.

Note to Investors

This press release contains certain forward-looking statements based on our current expectations, forecasts and assumptions that involve risks and uncertainties. This release does not constitute an offer to sell or a solicitation of offers to buy any securities of the Company. Forward-looking statements in this release are based on information available to us as of the date hereof. Our actual results may differ materially from those stated or implied in such forward-looking statements, due to risks and uncertainties associated with our business, which include the risk factors disclosed in our Form 10-K/A filed on April 28, 2011. Forward-looking statements include statements regarding our expectations, beliefs, intentions or strategies regarding the future and can be identified by forward-looking words such as "anticipate," " believe," "could," "estimate," "expect," "intend," "may," "should," and "would" or similar words. We assume no obligation to update the information included in this press release, whether as a result of new information, future events or otherwise. The Form 10-K/A filed on April 28, 2011, together with this press release and the financial information contained herein, are available on our website, www.merrimanco.com. Please click on "Investor Relations."

SOURCE Merriman Holdings, Inc.